2021年CUA和CUOG指南：去势抵抗性前列腺癌（CRPC）的管理

2021-02-10 加拿大泌尿外科协会 Can Urol Assoc J . 2021 Feb;15(2):E81-E90. doi: 10.5489/cuaj.7074.

2021年加拿大泌尿外科协会（CUA）-加拿大泌尿肿瘤学小组（CUOG）指南：去势抵抗性前列腺癌（CRPC）的管理

中文标题：

发布机构：

加拿大泌尿外科协会

发布日期：

2021-02-10

简要介绍：

2021年加拿大泌尿外科协会（CUA）-加拿大泌尿肿瘤学小组（CUOG）指南：去势抵抗性前列腺癌（CRPC）的管理

相关资料下载：

GetToolGuiderByIdResponse(projectId=1, id=b94f51c002053ede, title=2021年CUA和CUOG指南：去势抵抗性前列腺癌（CRPC）的管理 , enTitle=, guiderFrom=Can Urol Assoc J . 2021 Feb;15(2):E81-E90. doi: 10.5489/cuaj.7074., authorId=0, author=, summary=2021年加拿大泌尿外科协会（CUA）-加拿大泌尿肿瘤学小组（CUOG）指南：去势抵抗性前列腺癌（CRPC）的管理, cover=, journalId=0, articlesId=null, associationId=1160, associationName=加拿大泌尿外科协会, associationIntro=null, copyright=0, guiderPublishedTime=Wed Feb 10 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=2021年加拿大泌尿外科协会（CUA）-加拿大泌尿肿瘤学小组（CUOG）指南：去势抵抗性前列腺癌（CRPC）的管理, tagList=[TagDto(tagId=781, tagName=前列腺癌)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=26, categoryName=泌尿外科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=20620, categoryName=肿瘤医学网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=1, opened=0, paymentType=, paymentAmount=20, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5551, appHits=110, showAppHits=0, pcHits=993, showPcHits=5441, likes=0, shares=6, comments=4, approvalStatus=1, publishedTime=Wed Feb 10 19:31:41 CST 2021, publishedTimeString=2021-02-10, pcVisible=1, appVisible=1, editorId=4754896, editor=fbzhang, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=fbzhang, createdTime=Wed Feb 10 19:31:36 CST 2021, updatedBy=4754896, updatedName=fbzhang, updatedTime=Sat Jan 06 22:54:02 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=7074-Article Text-35534-1-10-20210201.pdf)])

7074-Article Text-35534-1-10-20210201.pdf

下载请点击：

评论区 (4)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=1005350, encodeId=78f510053500f, content=点赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60285465251, createdName=ms4000002095488795, createdTime=Thu Aug 05 13:26:24 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967332, encodeId=d3df96e332d9, content=分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc905505382, createdName=ms8000000769818805, createdTime=Thu May 20 22:17:42 CST 2021, time=2021-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967327, encodeId=adfd96e32742, content=点赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc905505382, createdName=ms8000000769818805, createdTime=Thu May 20 22:14:21 CST 2021, time=2021-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924236, encodeId=450d92423628, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210127/50a003c4097845e182c08afd64d8a509/bd766dfebe9c40e0bca2dae964601bdc.jpg, createdBy=22de5454917, createdName=carrotlyl, createdTime=Fri Feb 12 07:46:43 CST 2021, time=2021-02-12, status=1, ipAttribution=)]
2021-08-05 ms4000002095488795

点赞

90 0
[GetPortalCommentsPageByObjectIdResponse(id=1005350, encodeId=78f510053500f, content=点赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60285465251, createdName=ms4000002095488795, createdTime=Thu Aug 05 13:26:24 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967332, encodeId=d3df96e332d9, content=分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc905505382, createdName=ms8000000769818805, createdTime=Thu May 20 22:17:42 CST 2021, time=2021-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967327, encodeId=adfd96e32742, content=点赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc905505382, createdName=ms8000000769818805, createdTime=Thu May 20 22:14:21 CST 2021, time=2021-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924236, encodeId=450d92423628, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210127/50a003c4097845e182c08afd64d8a509/bd766dfebe9c40e0bca2dae964601bdc.jpg, createdBy=22de5454917, createdName=carrotlyl, createdTime=Fri Feb 12 07:46:43 CST 2021, time=2021-02-12, status=1, ipAttribution=)]
2021-05-20 ms8000000769818805

分享

91 0
[GetPortalCommentsPageByObjectIdResponse(id=1005350, encodeId=78f510053500f, content=点赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60285465251, createdName=ms4000002095488795, createdTime=Thu Aug 05 13:26:24 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967332, encodeId=d3df96e332d9, content=分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc905505382, createdName=ms8000000769818805, createdTime=Thu May 20 22:17:42 CST 2021, time=2021-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967327, encodeId=adfd96e32742, content=点赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc905505382, createdName=ms8000000769818805, createdTime=Thu May 20 22:14:21 CST 2021, time=2021-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924236, encodeId=450d92423628, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210127/50a003c4097845e182c08afd64d8a509/bd766dfebe9c40e0bca2dae964601bdc.jpg, createdBy=22de5454917, createdName=carrotlyl, createdTime=Fri Feb 12 07:46:43 CST 2021, time=2021-02-12, status=1, ipAttribution=)]
2021-05-20 ms8000000769818805

点赞

111 0
[GetPortalCommentsPageByObjectIdResponse(id=1005350, encodeId=78f510053500f, content=点赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60285465251, createdName=ms4000002095488795, createdTime=Thu Aug 05 13:26:24 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967332, encodeId=d3df96e332d9, content=分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc905505382, createdName=ms8000000769818805, createdTime=Thu May 20 22:17:42 CST 2021, time=2021-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967327, encodeId=adfd96e32742, content=点赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc905505382, createdName=ms8000000769818805, createdTime=Thu May 20 22:14:21 CST 2021, time=2021-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924236, encodeId=450d92423628, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210127/50a003c4097845e182c08afd64d8a509/bd766dfebe9c40e0bca2dae964601bdc.jpg, createdBy=22de5454917, createdName=carrotlyl, createdTime=Fri Feb 12 07:46:43 CST 2021, time=2021-02-12, status=1, ipAttribution=)]
2021-02-12 carrotlyl

感谢分享

109 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

肿瘤科指南

2021年CUA和CUOG指南：去势抵抗性前列腺癌（CRPC）的管理

相关指南

科室

工具

服务